Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

South Korea

MFDS approval does not guarantee reimbursement. HIRA assesses benefit suitability, NHIS negotiates price and MOHW publishes the final listing.

MFDS
HIRA
HIRA
NHIS
MOHW
5 decision nodes8 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it